This is a competing continuation application for the Pediatric Cardiomyopathy Registry (PCMR), an NHLBI program that has registered and analyzed 2920 children with cardiomyopathy. The underlying incidence, prevalence, and etiologies of cardiomyopathies are currently under study. In the current grant application, there will be three Specific Aims. The first expands on the natural history of cardiomyopathy and transplantation by integrating the PCMR and the Pediatric Heart Transplant Study databases in order to examine whether and how cardiac transplantation modifies the clinical course of cardiomyopathy in children. The second specific aim focuses on the functional status of pediatric cardiomyopathy patients. We propose to establish the longitudinal course of functional status in children with cardiomyopathy, and analyze the relationship to clinical events and outcomes. This will be accomplished by assessment of the functional status of pediatric cardiomyopathy patients, including the subset of children undergoing heart transplantation, by continuation of the current PCMR Functional Status Substudy and extension of the study to children in the post-transplant-period period. The third specific aim relates to viral and genetic testing and will investigate how genetic and viral markers of cardiomyopathy are associated with clinical and functional outcomes. We will collect cardiac tissue and blood samples from 300 children with cardiomyopathy for viral genome and genetic screening 9G4.5 gene) using the Pediatric Cardiomyopathy Repository, and correlate the results to clinical outcome. These studies will dramatically increase our understanding of pediatric cardiomyopathy, suggest new areas of research and improved patient management.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL053392-15
Application #
7649430
Study Section
Epidemiology of Chronic Diseases Study Section (ECD)
Program Officer
Kaltman, Jonathan R
Project Start
1995-09-30
Project End
2012-05-31
Budget Start
2009-06-01
Budget End
2012-05-31
Support Year
15
Fiscal Year
2009
Total Cost
$951,890
Indirect Cost
Name
University of Miami School of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Bansal, Neha; Barach, Paul; Amdani, Shahnawaz M et al. (2018) When is early septal myectomy in children with hypertrophic cardiomyopathy justified? Transl Pediatr 7:362-366
Lipshultz, Steven E (2018) Letter by Lipshultz Regarding Article, ""Anthracycline Cardiotoxicity: Worrisome Enough to Have You Quaking?"" Circ Res 122:e62-e63
Castleberry, Chesney D; Jefferies, John L; Shi, Ling et al. (2018) No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy. JACC Heart Fail 6:222-230
Lee, Teresa M; Hsu, Daphne T; Kantor, Paul et al. (2017) Pediatric Cardiomyopathies. Circ Res 121:855-873
Rusconi, Paolo; Wilkinson, James D; Sleeper, Lynn A et al. (2017) Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group. Circ Heart Fail 10:
Temple, Jennifer L; Bernard, Christophe; Lipshultz, Steven E et al. (2017) The Safety of Ingested Caffeine: A Comprehensive Review. Front Psychiatry 8:80
Singh, Rakesh K; Canter, Charles E; Shi, Ling et al. (2017) Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy. J Am Coll Cardiol 70:2663-2673
Hutchins, Kelley K; Siddeek, Hani; Franco, Vivian I et al. (2017) Prevention of cardiotoxicity among survivors of childhood cancer. Br J Clin Pharmacol 83:455-465
Sleeper, Lynn A; Towbin, Jeffrey A; Colan, Steven D et al. (2016) Health-Related Quality of Life and Functional Status Are Associated with Cardiac Status and Clinical Outcome in Children with Cardiomyopathy. J Pediatr 170:173-80.e1-4
Martherus, Ruben; Jain, Rahul; Takagi, Ken et al. (2016) Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt/?-catenin signaling. Am J Physiol Heart Circ Physiol 310:H174-87

Showing the most recent 10 out of 99 publications